Living with antipsychotic medication side-effects: The experience of Australian mental health consumers

International Journal of Mental Health Nursing

Volumn 24, Issue 3, 2015, Pages 253-261

  Morrison, Paul ^a   Meehan, Tom ^b,c   Stomski, Norman Jay ^a  

^a MURDOCH UNIVERSITY   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c Centre for Mental Health   (Australia)

Author keywords

Antipsychotic medication; Consumer; Interviews; Mental health; Qualitative research

Indexed keywords

NEUROLEPTIC AGENT;

ADAPTIVE BEHAVIOR; ADULT; DOSE RESPONSE; HUMAN; MALE; NURSING; PSYCHOLOGICAL INTERVIEW; PSYCHOLOGY; PSYCHOTIC DISORDERS; QUALITATIVE RESEARCH; RELAXATION TRAINING; SELF CARE; TREATMENT OUTCOME;

ADAPTATION, PSYCHOLOGICAL; ADULT; ANTIPSYCHOTIC AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INTERVIEW, PSYCHOLOGICAL; MALE; PSYCHOTIC DISORDERS; QUALITATIVE RESEARCH; RELAXATION THERAPY; SELF CARE; TREATMENT OUTCOME;

EID: 84929842760     PISSN: 14458330     EISSN: 14470349     Source Type: Journal    
DOI: 10.1111/inm.12110     Document Type: Article

References (46)

1. Appelbaum, P. S. & Le Melle, S. (2008). Techniques used by assertive community treatment (ACT) teams to encourage adherence: Patient and staff perceptions. Community Mental Health Journal, 44, 459-464.
2. Arana, G. W. (2000). An overview of side effects caused by typical antipsychotics. The Journal of Clinical Psychiatry, 61 (Suppl. 8), 5-11.
3. Awad, A. G. & Voruganti, L. N. (2004). New antipsychotics, compliance, quality of life, and subjective tolerability--are patients better off? Canadian Journal of Psychiatry, 49, 297-302.
4. Awad, A. G., Voruganti, L. N., Heslegrave, R. J. & Hogan, T. P. (1996). Assessment of the patient's subjective experience in acute neuroleptic treatment: Implications for compliance and outcome. International Clinical Psychopharmacology, 11 (Suppl. 2), 55-59.
5. Bentall, R. P. (2010). Doctoring the Mind: Why Psychiatric Treatments Fail. London: Penguin.
6. Berg, B. (2009). Qualitative Research Methods for the Social Sciences, 8th edn. Boston, MA: Allyn & Bacon.
7. Britten, N., Riley, R. & Morgan, M. (2010). Resisting psychotropic medicines: A synthesis of qualitative studies of medicine-taking. Advances in Psychiatric Treatment, 16, 207-218.
8. Browne, S., Garavan, J., Gervin, M., Roe, M., Larkin, C. & O'callaghan, E. (1998). Quality of life in schizophrenia: Insight and subjective response to neuroleptics. The Journal of Nervous and Mental Disease, 186, 74-78.
9. Burnard, P. (1991). A method of analysing interview transcripts in qualitative research. Nurse Education Today, 11, 461-466.
10. Burnard, P. (1996). Teaching the analysis of textual data: An experiential approach. Nurse Education Today, 16, 278-281.
11. Craven, M. A. & Bland, R. (2006). Better practices in collaborative mental health care: An analysis of the evidence base. Canadian Journal of Psychiatry, 51, 1S-71S.
12. Day, J., Wood, G., Dewey, M. & Bentall, R. (1995). A self-rating scale for measuring neuroleptic side-effects. Validation in a group of schizophrenic patients. British Journal of Psychiatry, 166, 650-653.
13. Deegan, P. E. (2005). The importance of personal medicine: A qualitative study of resilience in people with psychiatric disabilities. Scandinavian Journal of Public Health. Supplement, 66, 9-35.
14. Garavan, J., Browne, S., Gervin, M., Lane, A., Larkin, C. & O'Callaghan, E. (1998). Compliance with neuroleptic medication in outpatients with schizophrenia; relationship to subjective response to neuroleptics; attitudes to medication and insight. Comprehensive Psychiatry, 39, 215-219.
15. Gray, R., Wykes, T. & Gournay, K. (2002). From compliance to concordance: A review of the literature on interventions to enhance compliance with antipsychotic medication. Journal of Psychiatric and Mental Health Nursing, 9, 277-284.
16. Happell, B., Manias, E. & Roper, C. (2004). Wanting to be heard: Mental health consumers' experiences of information about medication. International Journal of Mental Health Nursing, 13, 242-248.
17. Hartling, L., Abou-Setta, A. M., Dursun, S., Mousavi, S. S., Pasichnyk, D. & Newton, A. S. (2012). Antipsychotics in adults with schizophrenia: Comparative effectiveness of first-generation versus second-generation medications: A systematic review and meta-analysis. Annals of Internal Medicine, 157, 498-511.
18. Johnson, F. R., Ozdemir, S., Manjunath, R., Hauber, A. B., Burch, S. P. & Thompson, T. R. (2007). Factors that affect adherence to bipolar disorder treatments: A stated-preference approach. Medical Care, 45, 545-552.
19. Jones, M. & Grey, R. (2008). Time to wake up and smell the coffee: Antipsychotic medication and schizophrenia. Journal of Psychiatric and Mental Health Nursing, 15, 344-348.
20. Kvale, S. & Brinkmann, S. (2009). Interviews: Learning the Craft of Qualitative Research Interviewing, 2nd edn. Los Angeles, CA: Sage Publications.
21. Leucht, S., Arbter, D., Engel, R. R., Kissling, W. & Davis, J. M. (2009a). How effective are second-generation antipsychotic drugs? A meta-analysis of placebo-controlled trials. Molecular Psychiatry, 14, 429-447.
22. Leucht, S., Corves, C., Arbter, D., Engel, R. R., Li, C. & Davis, J. M. (2009b). Second-generation versus first-generation antipsychotic drugs for schizophrenia: A metaanalysis. Lancet, 373, 31-41.
23. Lieberman, J. A., Stroup, T. S., McEvoy, M. D. etal. (2005). Effects of antipsychotic drugs in patients with chronic schizophrenia. The New England Journal of Medicine, 353, 1209-1223.
24. Marder, S. R. (1999). Antipsychotic drugs and relapse prevention. Schizophrenic Research, 35, S87-S92.
25. McCann, T. V. & Clark, E. (2004). Embodiment of severe and enduring mental illness: Finding meaning in schizophrenia. Issues in Mental Health Nursing, 25, 783-798.
26. Meehan, T., McCombes, S. & Stedman, T. (2007). Integrating psychosocial rehabilitation and psychotherapy. In: R. King, C. Lloyd & T. Meehan (Eds). Handbook of Psychosocial Rehabilitation. (pp. 87-101). Oxford: Blackwell Publishing.
27. Meehan, T., Stedman, T. & Wallace, J. (2011). Consumer strategies for coping with antipsychotic medication side effects. Australas Psychiatry, 19, 74-77.
28. Miller, D. D., Caroff, S. N., Davis, S. M. etal. (2008). Extrapyramidal side-effects of antipsychotics in a randomised trial. The British Journal of Psychiatry, 193, 279-288.
29. Moritz, S., Peters, M. J. V., Karow, A., Deljkovic, A., Tonn, P. & Naber, D. (2009). Cure or curse? Ambivalent attitudes towards neuroleptic medication in schizophrenia and non-schizophrenia patients. Mental Illness, 1, 1-9.
30. Morrison, A. P., Hutton, P., Shiers, D. & Turkington, D. (2012a). Antipsychotics: Is it time to introduce patient choice? The British Journal of Psychiatry, 201, 83-84.
31. Morrison, A. P., French, P., Stewart, S. L. etal. (2012b). Early detection and intervention evaluation for people at risk of psychosis: Multisite randomised controlled trial. BMJ (Clinical Research Ed.), 344, doi:10.1136/bmj.e2233.
32. Morrison, P., Meehan, T., Gaskill, D., Lunney, P. & Collings, P. (2000). The use of the Liverpool University Neuroleptic Side-Effect Rating Scale (LUNSERS) in clinical practice. The Australian and New Zealand Journal of Mental Health Nursing, 9, 166-176.
33. Oliver, P. & Jupp, V. (2006). Purposive sampling. In: Jupp V. (Ed.). The SAGE Dictionary of Social Research Methods. (pp. 245-246). London: Sage.
34. Peluso, M. J., Lewis, S. W., Barnes, T. R. & Jones, P. B. (2012). Extrapyramidal motor side-effects of first- and second-generation antipsychotic drugs. The British Journal of Psychiatry, 200, 387-392.
35. Pilling, S., Bebbington, P., Kuipers, E. etal. (2002). Psychological treatments in schizophrenia: I. Meta-analysis of family intervention and cognitive behaviour therapy. Psychological Medicine, 32, 763-782.
36. Roe, D. & Swarbrick, M. (2007). A recovery-oriented approach to psychiatric medication: Guidelines for nurses. Journal of Psychosocial Nursing and Mental Health Services, 45, 35-40.
37. Rogers, A., Day, J. C., Williams, B. etal. (1998). The meaning and management of neuroleptic medication: A study of patients with a diagnosis of schizophrenia. Social Science and Medicine, 47, 1313-1323.
38. Royal Australiannew Zealand College of Psychiatrists Clinical Practice Guidelines Team for the Treatment of Schizophrenia Related Disorders (2005). Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the treatment of schizophrenia and related disorders. The Australian and New Zealand Journal of Psychiatry, 39, 1-30.
39. Rummel-Kluge, C., Komossa, K., Schwarz, S. etal. (2012). Second-generation antipsychotic drugs and extrapyramidal side effects: A systematic review and meta-analysis of head-to-head comparisons. Schizophrenia Bulletin, 38, 167-177.
40. Salomon, C. & Hamilton, B. (2013). 'All roads lead to medication?' Qualitative responses from an Australian first-person survey of antipsychotic discontinuation. Psychiatric Rehabilitation Journal, 36, 160-165.
41. Seale, C., Chaplin, R., Lelliott, P. & Quirk, A. (2007). Antipsychotic medication, sedation and mental clouding: An observational study of psychiatric consultations. Social Science and Medicine, 65, 698-711.
42. Sullivan, W. P. & Floyd, D. F. (2012). There's more than meets the eye: The nuances of case management. J Soc Work. Disability and Rehabilitation, 11, 184-196.
43. Taylor, D., Paton, C. & Kerwin, R. (2005). The South London Maudsley Prescribing Guidelines, 8th edn. London: Martin Dunitz.
44. Tranulis, C., Goff, D., Henderson, D. C. & Freudenreich, O. (2011). Becoming adherent to antipsychotics: A qualitative study of treatment-experienced schizophrenia patients. Psychiatric Services, 62, 888-892.
45. Tuohy, D., Cooney, A., Dowling, M., Murphy, K. & Sixsmith, J. (2013). An overview of interpretive phenomenology as a research methodology. Nurse Researcher, 20, 17-20.
46. Wykes, T., Steel, C., Everitt, B. & Tarrier, N. (2008). Cognitive behavior therapy for schizophrenia: Effect sizes, clinical models, and methodological rigor. Schizophrenia Bulletin, 34, 523-537.